through V, and toxic shock syndrome toxin-1
(TSST-1). These enterotoxins are similar in activity,
sequence, structure, and molecular mass
(25-30 kDa).1-3 SEA and SEB are known as
superantigens due
MgCl2 (M2393) 2 mM MgCl2 (M2393)
25 mM HEPES (H4034) 25 mM HEPES (H4034)
30 mM Glucose (G7021) 30 mM Glucose (G7021)
1-15 µM Dye
Usage:
To cause presynaptic
release, vesicle fusion, and
dye unloading
B through V, and toxic shock syndrome toxin-1
(TSST-1). These enterotoxins are similar in activity,
sequence, structure, and molecular mass
(25-30 kDa).1-3 SEA and SEB are known as
superantigens due
Recovery > 30%) dark violet colonies with precipitating zone
(24h)
Streptococcus faecalis (29212) - -
Staphylococcus aureus (25923) - -
References:
1. WHO Technical Report series N. 598, Geneva
Number Content
1 β-Glucuronidase from
E. coli K 12
Enzyme in 50% glycerol,
pH approximately 6.5.
03 707 580 001 1 bottle,
1 ml
03 707 598 001 1 bottle,
5 ml
03 707 601 001
determining the optimal working dilutions by titration.
References
1. Korb, E., and Finkbeiner, S., Trends Neurosci., 34,
591-598 (2011).
2012 Sigma-Aldrich Co. LLC. All rights reserved
References
1. Harper S. and Speicher DW., Methods Mol
Biol., 681, 259-80 (2011).
2. Brazdova M., et al., PLoS ONE, 8, e59567
(2013).
3. Stefan E., et al., Nat Commun., 2, 598 (2011).
4. Heyne
through V, and toxic shock
syndrome toxin-1 (TSST-1). These enterotoxins are
similar in activity, sequence, structure, and molecular
mass (25–30 kDa).
1-3
SEA along with SEB are known as superantigens
through V, and toxic
shock syndrome toxin-1 (TSST-1). These enterotoxins
are similar in activity, sequence, structure, and
molecular mass (25-30 kDa).
1-3
SEA and SEB are known as superantigens
Brewer, Clear liquid mediums for the “aerobic” cultivation of anaerobes, J. Amer. Med. Assoc.,
115, 598-600 (1940)
4. C.R. Falk, H. Bucca, M.P. Simmons, A comparative study of the use of varying concentrations
Bagrodia, S., et al., J. Biol. Chem., 270, 22731
(1995).
17. Brown, J. L., et al., Curr. Biol., 6, 598 (1996).
18. Hill, C. S., et al., Cell, 81, 1159 (1995).
19. Manser, E., et al., Nature, 367, 40 (1994
References
1. Sperling S et al. (2005) hum mutat 26:575–582
2. Garg V et al. (2003) Nature 424:443–447
3. Schott JJ et al. (1998) Science 281:108–111
4. Toenjes m et al. (2008) mol Biosyst 4:589–598
Biochemica
D, Sigma
SAB5300133).
References
1. Sporikova Z, et al., (2018) Clin Breast Cancer 18(5): e841-e850.
2. Chen Z et al., (2018) Cancer Biol Ther 19(7): 598-608.
3. Soule HD et al., (1990) Cancer